Compound Detail
CHEMBL4761231
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4761231 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | WRMSEVOQIOBBOD-UHFFFAOYSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
585.9
MW (Da)
5.82
ALogP
4
HBA
0
HBD
63.4
PSA (Ų)
0.24
QED
2
Ro5 Violations
1
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 4.19
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| MCF7 | IC50 | = | 64940.0 | nM | 4.19 | Antitumor activity against human MCF7 cells assessed as inhibition of cell viabi... | 33065442 |
| HepG2 | IC50 | = | 90370.0 | nM | 4.04 | Antitumor activity against human HepG2 cells assessed as inhibition of cell viab... | 33065442 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 33065442 | 10.1016/j.bmc.2020.115674 | HCT-116 | 1 |
| 33065442 | 10.1016/j.bmc.2020.115674 | MCF7 | 1 |
| 33065442 | 10.1016/j.bmc.2020.115674 | HepG2 | 1 |
Data from ChEMBL 36 via Core Engine